Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03211520 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging:A Window to Anthracycline Toxicity
A clinical trial of Cardiac Complications, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 13
- Enrollment target
- 1
- Study location
NCT03211520 is a study of Cardiac Complications that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 13 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03211520, a study of Cardiac Complications, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is being conducted to see which cardiac tests that monitor how the heart functions during and after treatment with anthracyclines are most effective. This study will assess a new way to check the heart function of children during and after cancer treatment. Currently, doctors use echocardiograms (heart ultrasound) to see how the heart is working. Echocardiograms are currently being done as part of standard of care prior to giving anthracycline chemotherapy doses and if any cardiac problems are suspected. The new method involves Cardiac Magnetic Resonance Imagining (CMRI) and a blood tests for certain biomarkers for heart health: High sensitivity troponin, Caspase, C-reactive Protein (CRP), ventricular derived B-type natriuretic peptide (BNP), Matrix Metalloproteinases (MMPs), Tissue inhibitors of metalloproteinases (TIMPs), C terminal propeptide of type I procollagen (PICP), C terminal telopeptide of collagen type I (CITP), Troponin I, and Bone Alkaline Phosphatase. The purpose of this study is to find out if CMRI and blood tests help us to find heart problems earlier, before they are detected by echocardiograms.
Conditions Studied
Study Locations (1)
Connecticut
- Olga H Toro-Salazar - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-02 |
| Est. Completion | 2023-06-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03211520
The ClinicalTrials.gov registry entry for NCT03211520 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Complications appearing as the primary indexed condition, and to 0 interventions.
NCT03211520 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT03211520 about?
NCT03211520 is a clinical study titled "Magnetic Resonance Imaging:A Window to Anthracycline Toxicity". The study is being conducted to see which cardiac tests that monitor how the heart functions during and after treatment with anthracyclines are most effective. This study will assess a new way to check the heart function of children during and after cancer treatment. Currently, doctors use echocardi...
What is the current status of trial NCT03211520?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2013-02. Estimated completion is 2023-06-24.
What conditions does trial NCT03211520 study?
This clinical trial studies the following conditions: Cardiac Complications.
Who is sponsoring clinical trial NCT03211520?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03211520 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.